| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| Polyclonal antibody stimulator (Cancer Advances) | G-17DT | Phase 2 Clinical | Aphton Corp | Colorectal Neoplasms; Diabetes Mellitus, Type 1; Esophageal Neoplasms; Jaundice; Pancreatic Neoplasms; Stomach Neoplasms | Details |